Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,084 | 6,599 | 8,902 | 10,803 | 10,903 |
| TOTAL | $5,601 | $7,454 | $8,960 | $10,936 | $11,062 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 264 | 234 | 30 | 36 | 42 |
| TOTAL | $264 | $234 | $30 | $36 | $42 |
| Total Assets | $5,865 | $7,688 | $8,990 | $10,972 | $11,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 648 | 760 | 894 | 969 | 1,158 |
| Accrued Expenses | 97 | 97 | 96 | 95 | 96 |
| TOTAL | $2,697 | $2,960 | $2,948 | $3,198 | $3,642 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 122 |
| Deferred Revenues | 1,068 | 1,339 | 1,475 | 1,681 | 2,031 |
| Other Non-Current Liabilities | 157 | 144 | 0 | 3 | 7 |
| TOTAL | $157 | $144 | $N/A | $3 | $128 |
| Total Liabilities | $2,854 | $3,104 | $2,948 | $3,201 | $3,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,570 | 1,570 | 1,570 | 1,570 | 1,537 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -112,327 | -110,255 | -107,059 | -104,713 | -103,128 |
| TOTAL | $3,010 | $4,585 | $6,042 | $7,771 | $7,333 |
| Total Liabilities And Equity | $5,865 | $7,688 | $8,990 | $10,972 | $11,104 |